Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07812688) titled 'Effects of Allicin Pretreatment on Anti-oxidation Ability and Delayed Onset Muscle Soreness' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Guangxi Normal University
Condition:
Delayed Onset Muscle Soreness
Intervention:
Drug: allicin
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 1, 2024
Target Sample Size: 30
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07812688...